Introducing a research study for an investigational respiratory syncytial virus (RSV) vaccine given together with an annual flu vaccine.

Why is the study being done?

Respiratory syncytial virus is a common virus that causes lower respiratory infections.
Most people recover quickly from these infections, but infants and young children, older adults, and people with a weakened immune system may be at greater risk for more severe infections.
That’s why we’re enrolling people for the C3671006 RSV vaccine study. By taking part, you could help us learn more about the safety of the vaccine as well as your body’s immune response when it is given at the same time as an annual flu vaccine.

Who can participate in the study?

Eligible participants must:

  • Be 65 years of age or older
  • Be generally healthy or have stable chronic medical conditions
  • Not have a history of severe side effects from or allergic reactions to vaccines
  • Not had a flu vaccine in the last six months

What will participants be asked to do?

Participation includes three study visits at the John Hunter Hospital, blood tests and other study procedures, and lasts for about two months. The study vaccine flu vaccine and any study-related procedures will be provided to you at no cost. Taking part is voluntary and you may leave the study at any time.

How can I participate or find out more?

Download the Participation Information Sheet here

For more information and to express your interest please contact the Study Coordinator
Isabella Mackay or call 0448404581